Highly Sensitive B-Cell Monitoring Following B-Cell-Depleting Therapies: An Optimized Flow Cytometry Assay for Residual B-Cell Quantification

Oct 26, 2026

Posters

Oct 24, 2026

Lyophilized CompBeads for Flow Cytometer Alignment: When Does Instrument Drift Actually Matter?

Case Studies

Oct 20, 2026

Case Study: Validation of a High-Sensitivity Flow Cytometry Assay to Monitor B Cell Aplasia in Clinical Trials

Regulatory Sales One Pager 2026 Coverpage 791x1024

Brochure

Oct 16, 2026

Don’t Let Diagnostic Regulation Become Your Clinical Trial Bottleneck

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Highly Sensitive B-Cell Monitoring Following B-Cell-Depleting Therapies: An Optimized Flow Cytometry Assay for Residual B-Cell Quantification

Featured Resources

Lyophilized CompBeads for Flow Cytometer Alignment: When Does Instrument Drift Actually Matter?

Case Study: Validation of a High-Sensitivity Flow Cytometry Assay to Monitor B Cell Aplasia in Clinical Trials

Don’t Let Diagnostic Regulation Become Your Clinical Trial Bottleneck

One global CRO for your whole therapeutic development journey